Thomas Edwards, MD
Allergy & Immunology · Worcester, MANPI 1740215771
Payments from drug & device makers
Across 847 payments — averaging $27.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$5K
- Blueprint Medicines Corporation$5K
- GSK$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Pfizer$848
- Sanofi$782
- plus $7K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 207 | $5,482 |
| Blueprint Medicines Corporation | 23 | $5,367 |
| GSK | 163 | $2,499 |
| Regeneron Healthcare Solutions, Inc. | 72 | $1,444 |
| Pfizer | 44 | $848 |
| Sanofi | 33 | $782 |
| Novartis | 44 | $779 |
| CSL Behring | 29 | $776 |
| Genentech USA, Inc. | 32 | $755 |
| Amgen | 36 | $645 |
| Pharming Healthcare, Inc. | 13 | $484 |
| Grifols USA, LLC | 22 | $440 |
| Boehringer Ingelheim | 17 | $311 |
| Optinose US, Inc. | 16 | $309 |
| Teva Pharmaceuticals USA, Inc. | 28 | $296 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $270 |
| Kaleo, Inc. | 10 | $247 |
| Biocryst US Sales Co., LLC | 6 | $244 |
| AbbVie | 9 | $232 |
| Aimmune Therapeutics, Inc. | 7 | $147 |
| Lilly USA, LLC | 5 | $119 |
| Dermavant Sciences, Inc. | 1 | $105 |
| Sanofi-aventis U.S. LLC | 2 | $97 |
| Greer Laboratories, Inc. | 1 | $96 |
| Octapharma USA, Inc. | 4 | $88 |
| ADMA Biomanufacturing LLC | 1 | $51 |
| GC Biopharma USA, Inc. | 2 | $49 |
| Galderma Laboratories, L.p. | 3 | $49 |
| LEO Pharma Inc. | 2 | $42 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| Merck | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
How this compares
$23,107 in reported general payments places this provider in the 70th percentile of 114 allergy & immunology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Worcester
- Michelle ConroyWorcester$130K
- S David MillerNorth Dartmouth$8.7M
- Wanda PhipatanakulBoston$3.2M
- Maria CastellsGardner$2.8M
- Rima RachidBoston$1.1M
- Duane WesemannBoston$1M
- Matthew GiannettiBoston$720K
- John LeeBoston$695K
- Aleena BanerjiBoston$586K
- Michael PistinerBoston$468K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.